Jennison Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-58,139	Closed	-$1.36M	–	626
2021 Q4	$1.36M	Sell	58,139 -19,501	-25%	-$392K	﹤0.01%	579
2021 Q3	$1.29M	Buy	+77,640	New	+$1.5M	﹤0.01%	581
2021 Q1	–	Sell	-580,567	Closed	-$31M	–	664
2020 Q4	$31M	Buy	580,567 +428,136	+281%	+$21.3M	0.02%	290
2020 Q3	$6.29M	Buy	152,431 +608	+0.4%	+$26.3K	0.01%	419
2020 Q2	$7.36M	Sell	151,823 -15,404	-9%	-$739K	0.01%	404
2020 Q1	$7.07M	Buy	167,227 +17,642	+12%	+$727K	0.01%	370
2019 Q4	$6.4M	Buy	+149,585	New	+$6.51M	0.01%	416
2017 Q1	–	Sell	-1,372,679	Closed	-$39.6M	–	641
2016 Q4	$39.6M	Buy	+1,372,679	New	+$36.3M	0.04%	304
2016 Q2	–	Sell	-58,417	Closed	-$1.63M	–	632
2016 Q1	$1.63M	Sell	58,417 -534,789	-90%	-$11.7M	﹤0.01%	541
2015 Q4	$21.1M	Sell	593,206 -504,158	-46%	-$17.8M	0.02%	419
2015 Q3	$36.3M	Sell	1,097,364 -1,423,960	-56%	-$59.2M	0.04%	351
2015 Q2	$106M	Buy	2,521,324 +40,103	+2%	+$1.55M	0.1%	194
2015 Q1	$80.9M	Sell	2,481,221 -392,795	-14%	-$13.5M	0.07%	245
2014 Q4	$91.3M	Sell	2,874,016 -29,473	-1%	-$836K	0.09%	223
2014 Q3	$71.9M	Sell	2,903,489 -150,036	-5%	-$3.51M	0.07%	257
2014 Q2	$69M	Buy	3,053,525 +4,108	+0.1%	+$85.8K	0.06%	275
2014 Q1	$74.2M	Buy	3,049,417 +1,485,866	+95%	+$37.6M	0.07%	253
2013 Q4	$39.1M	Buy	1,563,551 +50,359	+3%	+$1.19M	0.04%	356
2013 Q3	$41.6M	Sell	1,513,192 -9,822	-0.6%	-$205K	0.04%	332
2013 Q2	$27.6M	Buy	+1,523,014	New	+$21M	0.03%	387